Category Archives: Institutional and special event

Livre blanc : étonnant vivant

La biologie vit en ce moment une véritable révolution. Que peut-on attendre des sciences de la vie dans ce siècle qui démarre ? Comment un pays comme le nôtre, riche de ses acquis, doit-il prendre en compte les formidables bouleversements à l’œuvre dans les sciences du vivant ? Après plusieurs mois de réflexion et de consultation, des centaines de chercheur.e.s révèlent les tournants scientifiques majeurs qui, en ce début du XXIe siècle, bouleversent les connaissances en sciences de la vie. Ils annoncent les révolutions attendues et les champs à explorer au cours des vingt prochaines années dans un livre blanc qui sera édité début 2017.

L’Inserm et la Fondation Bettencourt Schueller renforcent leur partenariat pour développer la formation des médecins­‐chercheurs de demain

La Fondation Bettencourt Schueller et l’Inserm réaffirment leur engagement mutuel pour la recherche scientifique de haut niveau en renouvelant la convention de l’Ecole de l’Inserm Liliane Bettencourt. Le soutien financier apporté par la Fondation permet chaque année à une vingtaine d’étudiants en médecine ou pharmacie de mener à bien leur double formation médecine-sciences, formation au soin et à la recherche.

Space and Health In the presence of the President of France, CNES and Inserm sign a framework agreement at the Elysée Palace

CNES and Inserm, respectively the institution in charge of proposing and implementing French space policy and the leading biomedical research organisation in Europe, have decided to expand their cooperation in the area of space and health. For the first time, they have signed a framework agreement that will cover the advances in basic research made possible by studying the human being in space, as well as the applications of findings from space research in matters of health.

Inserm, France’s rising research star according to Nature

The French National Institute of Health and Medical Research (Inserm) is the only research institution in France listed in the World Top 100 institutions with the most progress in the last 3 years. This is indicated by the Nature Index 2016 Rising Stars, which highlights the big contribution of Inserm researchers to publications in the best 68 journals selected by Nature. This ranking identifies the most brilliant institutions to watch in 2016 and in the coming years.

Objectives and performance contract signed between the State and Inserm for 2016–2020

On 11 July 2016, Mr Thierry Mandon, Secretary of State for Higher Education and Research, and the Chairman and CEO of the Institute, Professor Yves Lévy, signed the objectives and performance contract binding Inserm and the French State for the 2016–2020 period. The result of intense exchanges between Inserm and the relevant ministries, the contract defines the broad directions and actions that will be taken by the Institute in order to provide an environment conducive to the expression of talent, encourage the production of knowledge and best support its exploitation for societal, clinical or economic purposes, and enable laboratories to best respond to the new challenges and issues in the life sciences and health

Yves Lévy, Chairman and CEO of Inserm, appointed member of the UN “Global Health Crises” Task Force

UN Secretary-General Mr Ban Ki-moon has just announced the creation of a “Global Health Crises” Task Force, which will bring together 3 co-leads and 12 members, including Inserm Chairman and CEO Yves Lévy. The Task Force will ensure the implementation and monitoring of the recommendations of the report, “Protecting humanity from future health crises,” submitted to the UN Secretary-General in February 2016 by the High-level Panel on the Global Response to Health Crises[1]. The main mission of the Task Force will be to alert the UN Secretary-General on matters related to emerging crises and any gaps or weaknesses in the world health system.

Presentation of the French Plan for Genomic Medicine 2025

Remise du Plan Médecine Génomique 2025 à Manuel Valls

The French Plan for Genomic Medicine 2025 was presented to Prime Minister Manuel Valls by Yves Lévy, President of the National Alliance for Life Sciences and Health (Aviesan) and CEO of Inserm, on 22 June 2016.

A novel research program on traumatic memories

How will the traumatic events of the terrorist attacks of 13 November 2015 evolve in people’s memories, whether collective or individual? How does individual memory feed on collective memory and vice versa? Is it possible, by studying cerebral markers, to predict which victims will develop post-traumatic stress disorder and which will recover more quickly?

MSDAVENIR and Inserm sign a strategic framework agreement

Cyril Schiever, Chairman of the Board of MSDAVENIR, Professor Yves Lévy, Chairman and CEO of Inserm and Pascale Augé, President of the Executive Board of Inserm Transfert, today signed a strategic framework agreement to support French medical research.This event took place under the patronage and in the presence of Marisol Touraine, French Minister for Social Affairs and Health, and Thierry Mandon, Secretary of State for Higher Education and Research.

Dassault Systèmes and Inserm Announce Joint Agreement to Decipher Disease Complexity and Accelerate Clinical Research

Next Generation Scientific Innovation with the 3DEXPERIENCE Platform and Strategic Collaboration to Advance Programs in Aging, Cancer, Genomics and Microbiota

RSS Youtube